Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from ...
Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: — Goldman ...
Pfizer (PFE) faces allegations from Senator Ron Wyden (D-Ore.) of running the largest tax-avoidance scheme in Big Pharma.
With its stock down 5.4% over the past month, it is easy to disregard Pfizer (NYSE:PFE). We, however decided to ...
Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...
Senator Ron Wyden (D-Ore.), a senior member of the Senate Finance Committee, accused Pfizer (PFE) of carrying out what he ...
U.S. stock indexes are falling following President Donald Trump’s latest tariff escalation. The S&P 500 was down 0.5% in ...
Asian stocks are mostly lower as investors mull the uncertainties brought by U.S. President Donald Trump’s latest tariffs.
Wall Street edged lower after getting pulled in opposite directions as President Donald Trump’s latest tariff escalation creates winners and losers among auto stocks. The S&P 500 slipped 0.3% Thursday ...
Men and women who have taken to the air on behalf of the United States expressed bewilderment after the leak of attack plans. 5 min read Pam Bondi Suggests Signal Leak Is Unlikely to Be Criminally ...
Wall Street pointed lower in premarket trading Thursday after President Donald Trump announced he will slap 25% tariffs on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results